Importantly, hypoxia-associated factor (HAF, also known as SART1800 or squamous cell carcinoma antigen recognized by T cells) is an E3 ubiquitin ligase that mediates the HIF-1α to HIF-2α switch during ccRCC progression. Here, SART1 is linked to nonpapillary renal cell carcinoma.